Navigation Links
Cell Therapeutics, Inc. Adopts Shareholder Rights Plan
Date:12/28/2009

;s.eVar3=s.prop5;s.prop15='80188452';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.celltherapeutics.com/investors_alert">http://www.CellTherapeutics.com/investors_alert

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of CTI's securities. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general, and with pixantrone in particular, including, without limitation, the potential failure of pixantrone to prove safe and effective for the treatment of relapsed or refractory, aggressive non-Hodgkin's lymphoma as determined by the U.S. Food and Drug Administration, CTI's ability to continue to raise capital as needed to fund its operations, competitive factors technological developments, costs of developing, producing and selling pixantrone, and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.


    Media Contact:
    Dan Eramian
    T: 206.272.4343
    C: 206.854.1200
    E: deramian@ctiseattle.com
    www.CellTherapeutics.com/press_room

    Investors Contact:
    Ed Bell
    T: 206.282.7100
    Lindsey Jesch Logan
    T: 206.272.4347
    F: 206.272.4434

'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
(Date:7/30/2015)... (NYSE: RMD ) today announced results for its ... was $453.1 million, a 9 percent increase compared with ... increase on a constant currency basis).  Net income was ... 2014.  Diluted earnings per share for the quarter were ... The results for the quarter ended ...
(Date:7/30/2015)... 30, 2015  EP Global Communications, Inc. (Public OTC: ... contacted the Company about discussing EPGL,s electronic contact ... Monday, August 3, 2015.  Novartis CEO Joe ... the coming electronic contact lens market could be ... next several years.  Novartis partnered with Google in ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
(Date:7/31/2015)... Grand Rapids, MI (PRWEB) , ... July 31, ... ... Living Pure Essential Oils are 100% organic, natural, therapeutic-grade oils from ingredients sourced ... founder, Ashley Eilers, explains that “With considerable effort, we have developed the highest-quality ...
(Date:7/31/2015)... ... July 31, 2015 , ... “ Crack’em ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... mess while cooking. , Cooking can be a very messy experience, especially when cracking ...
(Date:7/31/2015)... FL (PRWEB) , ... July 31, 2015 , ... ... and distribution of a wide variety of nutritional and wellness products, announced the ... therapist that specializes in massage therapy, active isolated stretching and the prevention and ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... care client base, with the recent implementation of Microsoft Dynamics GP for a ... the industry, Intellitec is now supporting senior living communities in 16 states. This ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... (OSA) and the growing number of individuals who remain undiagnosed, treatment options for ... to shy away from traditional CPAP therapy due to its overall lack of ...
Breaking Medicine News(10 mins):Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Make Less Mess while Cooking with Crack’em 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Oravan Sleep Apnea Device Gains Traction in Sleep Industry 2
... blood pressure med , MONDAY, June 1 (HealthDay News) -- ... to one in five breast cancers that a blood pressure ... week,s issue of the Proceedings of the National Academy ... breast cells act like cancer cells. But tests on mice ...
... , PITTSBURGH, June 1 , , WHAT: ... invitation to testify before the U.S. House of Representatives Judiciary Subcommittee ... Delay: Are Patent Settlements That Delay Generic Drug Market Entry Anticompetitive?" ... Rep. John Conyers Jr. (D-MI). , , WHO: ...
... 1 The Job Opportunity Investment Network (JOIN) ... qualify more of the region,s underemployed workers and new job ... industries. JOIN, a regional funding collaborative founded in 2008, ... of workers in the Greater Philadelphia area who earn family-sustaining ...
... Experience of the Avalon Group,s Nominees , , ... (Nasdaq: PRSC ) today announced that two ... Governance, Inc. and Glass Lewis & Co., have issued ... Board of Directors nominees, Fletcher Jay McCusker and Kristi ...
... Effort to Bend Spending Curve to Help Move Health Reform ... statement was released today by Nancy H. Nielsen, M.D., President, ... http://www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ) , , "The American ... health sector today to outline initiatives to help achieve President ...
... Merck KGaA Study Reveals Wide Variations in Therapy Regimens, with ... in the US , , ORLANDO, Fla., June 1 ... cell lung cancer (NSCLC) patients, based on both age and ... Merck KGaA, Darmstadt, Germany, presented as a poster on Saturday ...
Cached Medicine News:Health News:Research Finds 'New Crop' of Breast Cancer Genes 2Health News:JOIN Funding Collaborative Connects Philadelphia Workers to Living-Wage Green, Healthcare Jobs 2Health News:JOIN Funding Collaborative Connects Philadelphia Workers to Living-Wage Green, Healthcare Jobs 3Health News:JOIN Funding Collaborative Connects Philadelphia Workers to Living-Wage Green, Healthcare Jobs 4Health News:JOIN Funding Collaborative Connects Philadelphia Workers to Living-Wage Green, Healthcare Jobs 5Health News:PROXY Governance and Glass Lewis Recommend That Stockholders Vote the White Proxy Card in Support of All Providence Nominees 2Health News:PROXY Governance and Glass Lewis Recommend That Stockholders Vote the White Proxy Card in Support of All Providence Nominees 3Health News:PROXY Governance and Glass Lewis Recommend That Stockholders Vote the White Proxy Card in Support of All Providence Nominees 4Health News:PROXY Governance and Glass Lewis Recommend That Stockholders Vote the White Proxy Card in Support of All Providence Nominees 5Health News:AMA Outlines Initiatives to White House to Help Slow Increases In Health Spending 2Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 2Health News:New Market Research Study Shows Lung Cancer Treatments Differ Significantly by Both Age and Geography 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: